Howard (Jack) West, MD, Associate Professor, City of Hope Cancer Center, Los Angeles, CA
Dr. West is a thoracic oncology specialist and Associate Clinical Professor in Medical Oncology at City of Hope Cancer Center. He also serves as Clinical Executive Director of AccessHope, providing remote cancer consult services.
Dr. West received an MPhil in Experimental Biology from Cambridge University on a Fulbright Scholarship and MD from Harvard Medical School. His internship and residency in internal medicine were at Harvard’s Brigham and Women’s Hospital, followed by medical oncology fellowship at the Fred Hutchinson Cancer Research Center in Seattle, WA. After co-leading thoracic oncology at Swedish Cancer Institute in Seattle for over 16 years, in 2019 he moved to the City of Hope to dedicate his focus on innovative approaches to delivering sub-specialist expertise across a broader geography, using tools such as remote case reviews and telemedicine consultations.
He has authored dozens of papers and chairs several CME programs and symposia internationally on thoracic oncology, novel educational approaches, and social media in cancer care. Dr. West is also Founder & President of Global Resource for Advancing Cancer Education (GRACE); Web Editor for JAMA Oncology; a regular correspondent for Medscape; and contributing author and section editor in lung cancer for UpToDate.
Financial relationships
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:AstraZenecaTopic:Lung CancerDate added:09/23/2021Date updated:09/29/2022
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Genentech/RocheTopic:Lung CancerDate added:09/23/2021Date updated:09/29/2022
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:MerckTopic:Lung CancerDate added:09/23/2021Date updated:09/29/2022
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:MiratiTopic:Lung CancerDate added:09/23/2021Date updated:09/29/2022
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:RegeneronTopic:Lung CancerDate added:09/23/2021Date updated:09/29/2022
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:TakedaTopic:Lung CancerDate added:09/23/2021Date updated:09/29/2022
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:AmgenTopic:Lung CancerDate added:09/29/2022Date updated:09/29/2022